100
Participants
Start Date
September 1, 2018
Primary Completion Date
July 31, 2019
Study Completion Date
August 1, 2019
Bifidobacterium breve B-3
160 mg of Bifidobacterium breve B-3 is orally administered per day for 12 weeks.
Control group
160 mg of placebo is orally administered per day for 12 weeks.
Integrated Research Institute for Natural Ingredients and Functional Foods, Yangsan
Pusan National University Yangsan Hospital
OTHER